Eden Research plc (LON:EDEN – Get Free Report) insider Lykele van der Broek acquired 256,000 shares of the firm’s stock in a transaction dated Thursday, February 6th. The shares were acquired at an average price of GBX 4 ($0.05) per share, with a total value of £10,240 ($12,703.14).
Eden Research Stock Down 2.6 %
Shares of EDEN stock opened at GBX 3.80 ($0.05) on Friday. The stock’s fifty day moving average price is GBX 3.89 and its 200 day moving average price is GBX 3.98. Eden Research plc has a 1-year low of GBX 3.30 ($0.04) and a 1-year high of GBX 6.20 ($0.08). The company has a market cap of £20.27 million, a price-to-earnings ratio of -200.00 and a beta of 0.92. The company has a debt-to-equity ratio of 1.25, a current ratio of 3.80 and a quick ratio of 2.42.
About Eden Research
Eden’s products are formulated with terpene active ingredients, based on natural plant defence metabolites.
See Also
- Five stocks we like better than Eden Research
- Best ESG Stocks: 11 Best Stocks for ESG Investing
- IBM’s AI Bet Pays Off—What’s Next for Investors?
- How to Calculate Stock Profit
- 3 Reasons to Treat AMD’s Drop as an Entry Opportunity
- What Are Dividend Champions? How to Invest in the Champions
- Qualcomm’s Post-Earnings Dip: A Prime Buying Opportunity?
Receive News & Ratings for Eden Research Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Eden Research and related companies with MarketBeat.com's FREE daily email newsletter.